Related Experiment Video
Updated: Sep 16, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
Spectrum of inherited metabolic disorders diagnosed through newborn screening and symptomatic referrals in Eastern
Sezai Arslan1, Filiz Ekinci Uğan2, Oğuzhan Yaralı3
1Department of Inherited Metabolic Diseases, Erzurum City Hospital, Erzurum, Turkey.
Objective:
Inherited metabolic disorders (IMDs) are heterogeneous genetic diseases whose observed spectrum is influenced by population characteristics, newborn screening (NBS), and diagnostic pathways.This study aimed to characterize confirmed IMDs diagnosed through NBS and symptomatic referrals at a tertiary center in Eastern Türkiye and estimate the regional burden of selected disorders.
Methods:
This retrospective study included patients evaluated between September 2022 and September 2024. IMDs were confirmed by biochemical and/or molecular genetic analyses. Population and live-birth data from the defined referral region were used to estimate regional and NBS-based birth prevalence.
Results:
Among 9603 patients evaluated, 828 (8.6%) had a confirmed IMDs; 580 (70.0%) were identified through NBS, 230 (27.8%) through symptomatic referral, and 18 (2.2%) through family screening. Vitamin and cofactor metabolism (43.8%) and amino acid metabolism disorders (35.7%) predominated. Biotinidase deficiency was the most frequent disorder (n = 360, 43.4%), including 316 (87.8%) partial and 44 (12.2%) profound cases. Neurological manifestations were the most frequent presentation among symptomatic patients (23.2%). Based on 61,409 estimated live births, estimated birth prevalence was 1:627 for the hyperphenylalaninemia/phenylketonuria spectrum and 1:543 for biotinidase deficiency. Minimum estimated regional prevalence was 1.07 and 0.97 per 100,000 for mucopolysaccharidoses and alkaptonuria, respectively.
Conclusion:
NBS and symptom-based evaluation are complementary diagnostic pathways for IMDs. The observed disease spectrum reflects the influence of screening strategies, while symptomatic referrals reveal broader clinical and genetic heterogeneity.
More Related Videos
14:57Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
Published on: October 10, 2020
07:05Measuring Enzymatic Activity of Neurodevelopmental Disorder-Associated Deubiquitylating Enzymes via an In Vitro Ubiquitin Chain Cleavage Assay
Published on: September 27, 2024
Related Concept Videos
Pedigree Analysis
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Automated Microbial Diagnostics